Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study

(1) Background: Neoadjuvant therapy is widely used to treat locally advanced breast cancer. It has been recently shown that it can also improve the prognosis of patients during the early stages of breast cancer. In the past, advanced breast cancer with positive Human Epidermal growth factor Receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chih-Chiang, Tsai, I-Chen, Hsu, Chiann-Yi, Lin, Hsin-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911223/
https://www.ncbi.nlm.nih.gov/pubmed/35268525
http://dx.doi.org/10.3390/jcm11051434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911223/
https://www.ncbi.nlm.nih.gov/pubmed/35268525
http://dx.doi.org/10.3390/jcm11051434

Ejemplares similares